2023 Q1 Form 10-Q Financial Statement

#000168316823004682 Filed on July 06, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q1
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.000K $1.870K
YoY Change 60.43%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00 $0.00
YoY Change
% of Gross Profit
Operating Expenses $3.000K $1.872K
YoY Change 60.26%
Operating Profit -$3.000K -$1.872K
YoY Change 60.26%
Interest Expense $0.00 $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00 $0.00
YoY Change
Pretax Income -$3.000K -$1.870K
YoY Change 60.43%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$3.000K -$1.872K
YoY Change 60.26%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 6.493M shares 6.493M shares
Diluted Shares Outstanding 6.493M shares 6.493M shares

Balance Sheet

Concept 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00 $0.00
YoY Change
Cash & Equivalents $0.00 $0.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $0.00 $0.00
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $0.00 $0.00
Total Long-Term Assets $0.00 $0.00
Total Assets $0.00 $0.00
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $105.7K $62.31K
YoY Change 69.67%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $105.7K $67.94K
YoY Change 55.6%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $105.7K $67.94K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $105.7K $67.94K
YoY Change 55.6%
SHAREHOLDERS EQUITY
Retained Earnings -$2.429M -$2.392M
YoY Change 1.58%
Common Stock $6.493K $6.493K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$105.7K -$67.94K
YoY Change
Total Liabilities & Shareholders Equity $0.00 $0.00
YoY Change

Cashflow Statement

Concept 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$3.000K -$1.872K
YoY Change 60.26%
Depreciation, Depletion And Amortization $0.00 $0.00
YoY Change
Cash From Operating Activities $0.00 $0.00
YoY Change -100.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $0.00 $0.00
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities $0.00 $0.00
Cash From Investing Activities $0.00 $0.00
Cash From Financing Activities $0.00 $0.00
Net Change In Cash $0.00 $0.00
YoY Change
FREE CASH FLOW
Cash From Operating Activities $0.00 $0.00
Capital Expenditures
Free Cash Flow $0.00 $0.00
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001415813
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 ARMC Other General And Administrative Income Expense
OtherGeneralAndAdministrativeIncomeExpense
usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
333-147187
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
UN MONDE INTERNATIONAL WORLDWIDE LTD.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
83-0500896
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
1-45A West Wilmot St
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Richmond Hill
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
ON
CY2023Q1 dei Entity Address Country
EntityAddressCountry
CA
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
L4B2P2
CY2023Q1 dei City Area Code
CityAreaCode
905
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
962-0823
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6493346 shares
CY2023Q1 us-gaap Cash
Cash
0 usd
CY2022Q4 us-gaap Cash
Cash
0 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
0 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
0 usd
CY2023Q1 us-gaap Assets
Assets
0 usd
CY2022Q4 us-gaap Assets
Assets
0 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
18101 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
15101 usd
CY2023Q1 ARMC Due To Related Parties Current1
DueToRelatedPartiesCurrent1
87620 usd
CY2022Q4 ARMC Due To Related Parties Current1
DueToRelatedPartiesCurrent1
87620 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
105721 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
102721 usd
CY2023Q1 us-gaap Liabilities
Liabilities
105721 usd
CY2022Q4 us-gaap Liabilities
Liabilities
102721 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6493346 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6493346 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6493346 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6493346 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
6493 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
6493 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2317217 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2317217 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2429431 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2426431 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-105721 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-102721 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
0 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
0 usd
CY2023Q1 us-gaap Revenues
Revenues
0 usd
CY2022Q1 us-gaap Revenues
Revenues
0 usd
CY2023Q1 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
3000 usd
CY2022Q1 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
0 usd
CY2022Q1 ARMC Other General And Administrative Income Expense
OtherGeneralAndAdministrativeIncomeExpense
1872 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
3000 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
1872 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1872 usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
0 usd
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
0 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-3000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-1872 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-3000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1872 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
0 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
0 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.000
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.000
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.000
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6493346 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6493346 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6493346 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6493346 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-66072 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1872 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-67944 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-102721 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-3000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-105721 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-3000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1872 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
0 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
0 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1771 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
0 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-101 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2023Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 usd
CY2022Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
101 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
101 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2021Q3 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
one-for-ten reverse stock split
us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
1276487 shares
CY2021Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
1276487 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6493346 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6493346 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6493346 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6493346 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
2429431 usd
CY2023Q1 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0 usd
CY2023Q1 ARMC Due To Related Parties Current And Noncurrent1
DueToRelatedPartiesCurrentAndNoncurrent1
87620 usd
CY2022Q4 ARMC Due To Related Parties Current And Noncurrent1
DueToRelatedPartiesCurrentAndNoncurrent1
87620 usd

Files In Submission

Name View Source Status
armc-20230331_def.xml Edgar Link unprocessable
0001683168-23-004682-index-headers.html Edgar Link pending
0001683168-23-004682-index.html Edgar Link pending
0001683168-23-004682.txt Edgar Link pending
0001683168-23-004682-xbrl.zip Edgar Link pending
armc-20230331.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
unmonde_ex3101.htm Edgar Link pending
unmonde_ex3102.htm Edgar Link pending
unmonde_ex3201.htm Edgar Link pending
unmonde_ex3202.htm Edgar Link pending
unmonde_i10q-033123.htm Edgar Link pending
armc-20230331_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
armc-20230331_lab.xml Edgar Link unprocessable
unmonde_i10q-033123_htm.xml Edgar Link completed
armc-20230331_pre.xml Edgar Link unprocessable